Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,340.00
-39.00 (-2.83%)
At close: Apr 28, 2026

Kwangdong Healthbio Market Cap

Kwangdong Healthbio has a market cap or net worth of 17.00 billion as of April 29, 2026. Its market cap has increased by 0.49% in one year.

Market Cap
17.00B
Enterprise Value
n/a
Revenue
38.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,340.00

Market Cap Chart

Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 17.00B, a decrease of -17.77%. That is a compound annual growth rate of -2.13%.

History

DateMarket Cap% Change
Apr 28, 202617.00B-14.87%
Dec 30, 202519.97B14.12%
Dec 30, 202417.50B-38.70%
Dec 28, 202328.55B23.01%
Dec 29, 202223.21B-12.02%
Dec 30, 202126.38B-4.04%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Future Medicine 18.55B
Union Korea Pharm 19.70B
CXI Healthcare Technology Group 15.54B
WooGene B&G 21.55B
BIFIDO 23.48B
Hurum 25.20B
Bioten 11.89B
Pharmsville 28.28B
Market Cap Rankings